IP Library › Granted Patent US 8,835,463
Granted Patent B2
US 8,835,463 · App. 13/409,853 · Granted Sep 16, 2014

Compounds having analgesic and/or immunostimulant activity

Inventors: Bertrand Leblond (Paris, FR); Eric Beausoleil (Paris, FR); Thierry Taverne (St. Martin Boulogne sur Mer, FR); John E. Donello (Dana Point, CA)
Assignees: Allergan, Inc.; Exonhit Therapeutics SA
C07D265/30A61K31/4025C07D319/18A61K31/4709A61K31/5377C07D213/64A61K31/4439C07D295/12A61K31/5375A61K31/541A61K31/4545A61K31/496A61K31/40A61K31/4409
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,835,463
App. No.
13/409,853
Granted
Sep 16, 2014
Kind
B2
Abstract

The compounds shown by their structural formulas in the specification have analgesic and or immunostimulant activity in mammals.

Claims (4)

1. A compound of formula (i) or of (ii)

where R 4 is H, alkyl of 1 to 6 carbons or CO—R 5 where R 5 is alkyl of 1 to 6 carbons, or a pharmaceutically acceptable salt of said compound.

2. A compound in accordance with claim 1 where R 4 is H.

3. A method of treating pain in a mammal in need of such treatment, comprising administering to said mammal the compound of claim 1 or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2012
From: ALLERGAN, INC.
To: ALLERGAN, INC.; EXONHIT THERAPEUTICS SA
Reel/Frame 028127/0159 →
Continuity (3)
Division 11814593
Provisional Application 60647271 · Jan 26, 2005
Related Publication 20120157497A1 · Jun 21, 2012